Risk Warning: Equity investments involve risks to your capital as well as potential rewards. Please be aware of our risk warning before investing through our platform.
Invest and Discover
Check out our newest campaigns to Invest in and Discover companies based on biotech and healthcare.
Life science: exciting investment opportunities with serious social impact.
Target:£450,000 Accepting Reservations Shares reserved
96%
Sales and licensing
Minimally Invasive (keyhole) Surgery
Medical Device
Game-changing medtech device investment opportunity coming soon.
Successful campaigns:
Please note not all percentages of capital raised outlined above were raised through the Capital Cell website itself.
Success Rate (Last 12 months)
Total Invested on Capital Cell
Successful campaigns
HOW IT WORKS
Equity investment is a way of buying shares in privately owned companies that are not yet on the stock market. The company gets the money it needs to grow, while the investors receive equity in return.
Capital Cell works with companies whose technology is based on biology or healthcare to secure the investment they need to progress their incredible, life-changing ideas.
The companies are analysed in-house, by a lead investor, and through the BioExpert Network. Only those passing all three checks get listed on the platform for investment.
Investing in early stage companies is always risky, but if the companies are successful in achieving their goals the financial rewards for investors can be significant, and the social impact can affect the lives of millions.
HOW IT WORKS
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris.Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Hostrud exercitation ullamco laboris.Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliquaUt enim ad minim veniam
The BioExpert Network, Capital Cell’s unique community for crowdsourcing due diligence expertise
The BioExpert Network is a community of PhD level scientists, IP lawyers, physicians, investment consultants and industry professionals.
The BioExpert Network provides detailed feedback on non-confidential pitch decks and business plans received by Capital Cell.
Experts review several factors including the science, team, innovations, financial merit and investability. Experts receive investment credit which can be invested in live Capital Cell campaigns.
Share your wisdom: apply to be a member today.
900+
experts
are members of the BioExpert Network
100+
Proposals
have been reviewed by our experts
“Capital Cell have identified the sweet spot for helping companies in the life science sector who are seeking funding between £250k and £2M. This industry niche is proving to be a hugely profitable and fast growing sector and personally I enjoy helping companies go from idea through to having the actual medicine or therapeutic at the end. I’m looking forward to our onward business journey together.”
“The platform is a great way to expand funding possibilities, reaching investors that we would have never been able to reach otherwise. Daniel and the team offered constant professional support throughout our campaign, helping us to become the first ever life science company in Spain to raise over 1M€ through equity crowdfunding; then dealt with all the complicated legal paperwork afterwards!”
“I came to know Capital Cell when looking to invest in a Company they were proposing in their platform. I was impressed by their ability to select companies with only the best growth potential as well as to close the rounds they proposed. When I heard they were opening to investors their capital base I didn’t let the opportunity pass by. Really glad to be part of this adventure.”
“The BioExpert Network is a fundamental part of the Capital Cell service. As members, we don’t only rate the exciting projects that are shared for the credit incentive… We get to be the first to know about the new bio-revolution. It’s a window into the future of applied life sciences at a glance – like a crystal ball for the fortune telling of healthcare!”
PROFITABILITY COMPARISON
Source: The UK Life Sciences Industry and the Public Markets, 2016/17 report, by BIA (Biotech Industry Association)
All UK companies: 7%
All companies operating in the UK healthcare sector: 16%
Small and growing healthcare companies on the UK Alternative Investment Market: 48%
Our Partners
We are working with some fantastic European partners, to improve the quality of our service to both investors and companies seeking funding.
Share your pitch deck
Each start up is different and we’ll treat you as an individual.
Share your pitch deck with us and you’ll receive a bespoke funding proposal, analytical report with detailed feedback, and recommendations to help you successfully raise the funds you need.